Myopia Profile

Eyerising Myopia Management Device

The Eyerising Myopia Management Device delivers Repeated Low-Level Red-Light (RLRL) therapy to the ocular fundus through semi-conductor laser diodes emitting 650nm visible red light. The Eyerising device has been demonstrated to increase choroidal blood flow and induce choroidal thickening, potentially addressing the scleral hypoxia implicated in myopia progression. It is backed by over 40 clinical studies, including 2-year clinical trial results showing myopia control efficacy.

Visit the Eyerising Myopia Management Device website.

Instrument
Eyerising International
Eyerising Myopia Management Device
Myopia control device that delivers repeated low-level red-light (RLRL) to the ocular fundus.
Securely shares patient compliance data with practitioners to monitor efficacy and safe use
 Silver Sponsor Light therapies

Articles on Eyerising Myopia Management Device.

Global insights on repeated low-level red light therapy: interview series A recent interview series with five experts from around the world sheds light on their experiences with RLRL. Read Full Article Efficacy of repeated low-level red light therapy for high myopia control This study found strong efficacy for high myopia and no adverse responses after 1 year of low-level red light therapy use.Read Full Article Boosting orthokeratology efficacy with repeated low-level red lightThis 1-year study investigated the efficacy and safety of combining orthokeratology and repeated low-level red-light (RLRL) therapyRead Full Article
Global insights on repeated low-level red light therapy: interview series A recent interview series with five experts from around the world sheds light on their experiences with RLRL. Read Full Article

Eyerising International resources

Eyerising.png

Eyerising International and Myopia Profile Interview Series: Highlights

Eyerising International recently undertook a series of video interviews where global experts spoke to Dr Kate Gifford of Myopia Profile about their clinical experiences, observations and work with the Eyerising Myopia Management Device.

To watch the interviews in full, please visit
https://www.eyerisinginternational.com/the-device/